Biofarma Group
Private Company
Funding information not available
Overview
Biofarma Group is a private, France-based biotech established in 2008, specializing in vaccines and biologics for infectious diseases. As a developer and manufacturer, it likely operates a hybrid business model combining proprietary R&D with contract services. While specific pipeline and financial details are not publicly disclosed, its strategic location in Lyon, a major European biopharma hub, positions it to serve significant public health markets, though it faces competition from large multinational vaccine producers.
Technology Platform
Inferred expertise in vaccine development and biologics manufacturing platforms; specific modalities not publicly disclosed.
Opportunities
Risk Factors
Competitive Landscape
Operates in a highly competitive market dominated by global giants like GSK, Sanofi, Pfizer, and Merck. Also competes with numerous biotech startups and CDMOs for talent, funding, and partnerships within the European biotech ecosystem.